Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: results of a self-reporting questionnaire.
Christen Vagts(University of Illinois Chicago), Robert P. Baughman(University of Cincinnati), Christian Ascoli(University of Illinois Chicago), Nabil William G Sweis(University of Jordan), Marc A. Judson(Cleveland Clinic), Nadera Sweiss(University of Illinois Chicago), Jaleel Jerry G. Sweis(University of Illinois Chicago), Athol U. Wells(St Thomas' Hospital), Elyse E. Lower(University of Cincinnati), Filippo M Martone(Associazione Italiana Vulvodinia Onlus), Paola Rottoli(University of Siena)
Cited by 2
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863